Europe Natural Killer (Nk) Cell Therapeutics Market - Industry Trends And Forecast To 2029
Description
Europe Natural Killer (Nk) Cell Therapeutics Market - Industry Trends And Forecast To 2029
Europe natural killer (NK) cell therapeutics market is projected to register a CAGR of 41.1% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021 and the forecast period is 2022 to 2029
Market Segmentation
Europe Natural Killer (NK) Cell Therapeutics Market, By Therapeutics (NK Cell Therapies, NK Cell Directed Antibodies), Approaches (Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC), Bispecific Antibodies), Application (Cancer, Acute Infectious Diseases, Gastrointestinal Diseases, Others), End User (Research & Academic Institutes, Hospitals, Specialty Clinics), Distribution Channel (Hospital Pharmacies, Direct Tender, Others), Country (Germany, France, Italy, U.K., Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, Luxembourg, rest of Europe) Industry Trends and Forecast to 2029
Some of the major factors contributing to the growth of the Europe natural killer (NK) cell therapeutics market are:
• Increase in patient population with chronic diseases
• Increasing investment in research and development
Market Players
The key market players for Europe natural killer (NK) cell therapeutics market are listed below:
• Merck KGaA
• Bristol-Myers Squibb Company
• Glycostem
• Kiadis Pharma
• Cytovia Therapeutics
• Nkarta, Inc.
• Nektar
• ImmunityBio, Inc.
• Brink Biologics, Inc.
• Biohaven Pharmaceuticals
• Fate Therapeutics
• EMERcell
• Phio Pharmaceuticals
• PersonGen BioTherapeutics
• Innate Pharma, Inc.
• INmuneBIO
• Gamida Cell
• Acepodia Inc.
• Affimed GmbH
• Multimmune GmbH
• iCell Gene Therapeutics
• Takeda Pharmaceutical Company Limited
• Regeneron Pharmaceuticals Inc.
Company Profiles
• Merck KGaA
• Bristol-Myers Squibb Company
• Glycostem
• Kiadis Pharma
• Cytovia Therapeutics
• Nkarta, Inc.
• Nektar
• ImmunityBio, Inc.
• Brink Biologics, Inc.
• Biohaven Pharmaceuticals
• Fate Therapeutics
• EMERcell
• Phio Pharmaceuticals
• PersonGen BioTherapeutics
• Innate Pharma, Inc.
• INmuneBIO
• Gamida Cell
• Acepodia Inc.
• Affimed GmbH
• Multimmune GmbH
• iCell Gene Therapeutics
• Takeda Pharmaceutical Company Limited
• Regeneron Pharmaceuticals Inc.
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
Europe natural killer (NK) cell therapeutics market is projected to register a CAGR of 41.1% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021 and the forecast period is 2022 to 2029
Market Segmentation
Europe Natural Killer (NK) Cell Therapeutics Market, By Therapeutics (NK Cell Therapies, NK Cell Directed Antibodies), Approaches (Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC), Bispecific Antibodies), Application (Cancer, Acute Infectious Diseases, Gastrointestinal Diseases, Others), End User (Research & Academic Institutes, Hospitals, Specialty Clinics), Distribution Channel (Hospital Pharmacies, Direct Tender, Others), Country (Germany, France, Italy, U.K., Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, Luxembourg, rest of Europe) Industry Trends and Forecast to 2029
Some of the major factors contributing to the growth of the Europe natural killer (NK) cell therapeutics market are:
• Increase in patient population with chronic diseases
• Increasing investment in research and development
Market Players
The key market players for Europe natural killer (NK) cell therapeutics market are listed below:
• Merck KGaA
• Bristol-Myers Squibb Company
• Glycostem
• Kiadis Pharma
• Cytovia Therapeutics
• Nkarta, Inc.
• Nektar
• ImmunityBio, Inc.
• Brink Biologics, Inc.
• Biohaven Pharmaceuticals
• Fate Therapeutics
• EMERcell
• Phio Pharmaceuticals
• PersonGen BioTherapeutics
• Innate Pharma, Inc.
• INmuneBIO
• Gamida Cell
• Acepodia Inc.
• Affimed GmbH
• Multimmune GmbH
• iCell Gene Therapeutics
• Takeda Pharmaceutical Company Limited
• Regeneron Pharmaceuticals Inc.
Company Profiles
• Merck KGaA
• Bristol-Myers Squibb Company
• Glycostem
• Kiadis Pharma
• Cytovia Therapeutics
• Nkarta, Inc.
• Nektar
• ImmunityBio, Inc.
• Brink Biologics, Inc.
• Biohaven Pharmaceuticals
• Fate Therapeutics
• EMERcell
• Phio Pharmaceuticals
• PersonGen BioTherapeutics
• Innate Pharma, Inc.
• INmuneBIO
• Gamida Cell
• Acepodia Inc.
• Affimed GmbH
• Multimmune GmbH
• iCell Gene Therapeutics
• Takeda Pharmaceutical Company Limited
• Regeneron Pharmaceuticals Inc.
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
Table of Contents
200 Pages
- 1 Introduction
- 1.1 Objectives Of The Study
- 1.2 Market Definition
- 1.3 Overview Of Europe Natural Killer (Nk) Cell Therapeutics Market
- 1.4 Limitations
- 1.5 Markets Covered
- 2 Market Segmentation
- 2.1 Markets Covered
- 2.2 Geographical Scope
- 2.3 Years Considered For The Study
- 2.4 Currency And Pricing
- 2.5 Dbmr Tripod Data Validation Model
- 2.6 Multivariate Modelling
- 2.7 Therapeutics Lifeline Curve
- 2.8 Primary Interviews With Key Opinion Leaders
- 2.9 Dbmr Market Position Grid
- 2.10 Secondary Sources
- 2.11 Assumptions
- 3 Executive Summary
- 3.1 Epidemiology
- 3.2 Pestel Analysis
- 3.3 Porter’s Five Forces Model
- 3.4 Industrial Insights:
- 3.5 Pipeline Analysis
- 4 Europe Natural Killer (Nk) Cell Therapeutics Market: Regulations
- 5 Market Overview
- 5.1 Drivers
- 5.1.1 Increase In Usage Of Natural Killer (Nk) Cells For The Treatment Of Cancer And Infectious Diseases
- 5.1.2 Increase In Patient Population With Chronic Diseases
- 5.1.3 Rise In Awareness About Immunotherapies
- 5.1.4 Adoption Of Natural Killer (Nk) Cell Therapy In Emerging Markets
- 5.2 Restraints
- 5.2.1 Lack Of Specificity And Poor In-vivo Survival Of The Cells
- 5.2.2 Adverse Side Effects Of Therapies
- 5.2.3 High Cost Associated With The Therapies
- 5.3 Opportunities
- 5.3.1 Advancement In Natural Killer (Nk) Cell Therapies
- 5.3.2 Strategic Initiatives By Market Players
- 5.3.3 Rise In Expenditure In Healthcare Sector
- 5.4 Challenges
- 5.4.1 Long Approval Time For Immunotherapies
- 5.4.2 Lack Of Specific Treatment By Natural Killer (Nk) Cells
- 5.4.3 Availability Of Alternatives For Tumor Treatment
- 6 Europe Natural Killer (Nk) Cell Therapeutics Market, By Therapeutics
- 6.1 Overview
- 6.2 Nk Cell Therapies
- 6.3 Nk Cell Directed Antibodies
- 7 Europe Natural Killer (Nk) Cell Therapeutics Market, By Approaches
- 7.1 Overview
- 7.2 Antibody-dependent Cell-mediated Cytotoxicity (Adcc)
- 7.3 Bispecific Antibodies
- 8 Europe Natural Killer (Nk) Cell Therapeutics Market, By Application
- 8.1 Overview
- 8.2 Cancer
- 8.2.1 Solid Tumors
- 8.2.2 Hematologic Malignancies
- 8.2.2.1 Multiple Myeloma
- 8.2.2.2 Acute Myeloid Leukemia (Aml)
- 8.2.2.3 Lymphoma
- 8.2.2.4 Others
- 8.2.3 Others
- 8.3 Immunoproliferative Disorders
- 8.4 Acute Infectious Diseases
- 8.5 Gastrointestinal Diseases
- 8.6 Others
- 9 Europe Natural Killer (Nk) Cell Therapeutics Market, By End User
- 9.1 Overview
- 9.2 Hospitals
- 9.3 Specialty Clinics
- 9.4 Research & Academic Institutes
- 10 Europe Natural Killer (Nk) Cell Therapeutics Market, By Distribution Channel
- 10.1 Overview
- 10.2 Hospital Pharmacies
- 10.3 Direct Tender
- 10.4 Others
- 11 Europe Natural Killer (Nk) Cell Therapeutics Market, By Region
- 11.1 Europe
- 11.1.1 Germany
- 11.1.2 France
- 11.1.3 Italy
- 11.1.4 U.K.
- 11.1.5 Spain
- 11.1.6 Netherlands
- 11.1.7 Russia
- 11.1.8 Switzerland
- 11.1.9 Turkey
- 11.1.10 Austria
- 11.1.11 Norway
- 11.1.12 Hungary
- 11.1.13 Lithuania
- 11.1.14 Ireland
- 11.1.15 Poland
- 11.1.16 Luxembourg
- 11.1.17 Rest Of Europe
- 12 Europe Natural Killer (Nk) Cells Therapeutics Market, Company Landscape
- 12.1 Company Share Analysis: Europe
- 13 Swot Analysis
- 14 Company Profile
- 14.1 Merck Kgaa
- 14.1.1 Company Snapshot
- 14.1.2 Recent Financials
- 14.1.3 Product Portfolio
- 14.1.4 Recent Developments
- 14.2 Bristol-myers Squibb Company
- 14.2.1 Company Snapshot
- 14.2.2 Recent Financials
- 14.2.3 Product Portfolio
- 14.2.4 Recent Developments
- 14.3 Glycostem
- 14.3.1 Company Snapshot
- 14.3.2 Product Portfolio
- 14.3.3 Recent Developments
- 14.4 Innate Pharma, Inc.
- 14.4.1 Company Snapshot
- 14.4.2 Revenue Analysis
- 14.4.3 Product Portfolio
- 14.4.4 Recent Developments
- 14.5 Regeneron Pharmaceuticals Inc.
- 14.5.1 Company Snapshot
- 14.5.2 Recent Financials
- 14.5.3 Product Portfolio
- 14.5.4 Recent Developments
- 14.6 Takeda Pharmaceutical Company Limited
- 14.6.1 Company Snapshot
- 14.6.2 Recent Financials
- 14.6.3 Product Portfolio
- 14.6.4 Recent Developments
- 14.7 Inmunebio
- 14.7.1 Company Snapshot
- 14.7.2 Revenue Analysis
- 14.7.3 Product Portfolio
- 14.7.4 Recent Developments
- 14.8 Kiadis Pharma
- 14.8.1 Company Snapshot
- 14.8.2 Revenue Analysis
- 14.8.3 Product Portfolio
- 14.8.4 Recent Developments
- 14.9 Acepodia Inc.
- 14.9.1 Company Snapshot
- 14.9.2 Product Portfolio
- 14.9.3 Recent Developments
- 14.10 Affimed Gmbh
- 14.10.1 Company Snapshot
- 14.10.2 Recent Financials
- 14.10.3 Product Portfolio
- 14.10.4 Recent Developments
- 14.11 Biohaven Pharmaceuticals
- 14.11.1 Company Snapshot
- 14.11.2 Revenue Analysis
- 14.11.3 Product Portfolio
- 14.11.4 Recent Developments
- 14.12 Brink Biologics, Inc.
- 14.12.1 Company Snapshot
- 14.12.2 Product Portfolio
- 14.12.3 Recent Development
- 14.13 Cytovia Therapeutics
- 14.13.1 Company Snapshot
- 14.13.2 Product Portfolio
- 14.13.3 Recent Developments
- 14.14 Emercell
- 14.14.1 Company Snapshot
- 14.14.2 Product Portfolio
- 14.14.3 Recent Developments
- 14.15 Fate Therapeutics
- 14.15.1 Company Snapshot
- 14.15.2 Revenue Analysis
- 14.15.3 Product Portfolio
- 14.15.4 Recent Developments
- 14.16 Gamida Cell
- 14.16.1 Company Snapshot
- 14.16.2 Product Portfolio
- 14.16.3 Recent Developments
- 14.17 Icell Gene Therapeutics
- 14.17.1 Company Snapshot
- 14.17.2 Product Portfolio
- 14.17.3 Recent Development
- 14.18 Immunitybio, Inc.
- 14.18.1 Company Snapshot
- 14.18.2 Revenue Analysis
- 14.18.3 Product Portfolio
- 14.18.4 Recent Developments
- 14.19 Multimmune Gmbh
- 14.19.1 Company Snapshot
- 14.19.2 Product Portfolio
- 14.19.3 Recent Developments
- 14.20 Nektar
- 14.20.1 Company Snapshot
- 14.20.2 Revenue Analysis
- 14.20.3 Product Portfolio
- 14.20.4 Recent Developments
- 14.21 Nkarta, Inc.
- 14.21.1 Company Snapshot
- 14.21.2 Product Portfolio
- 14.21.3 Recent Developments
- 14.22 Persongen Biotherapeutics
- 14.22.1 Company Snapshot
- 14.22.2 Product Portfolio
- 14.22.3 Recent Developments
- 14.23 Phio Pharmaceuticals
- 14.23.1 Company Snapshot
- 14.23.2 Product Portfolio
- 14.23.3 Recent Developments
- 15 Questionnaire
- 16 Related Reports
- List Of Tables
- Table 1 Europe Natural Killer (Nk) Cell Therapeutics Market, Pipeline Analysis
- Table 2 Europe Natural Killer (Nk) Cell Therapeutics Market, By Therapeutics, 2018-2029 (Usd Million)
- Table 3 Europe Nk Cell Therpaies In Natural Killer (Nk) Cell Therapeutics Market, By Region, 2018-2029 (Usd Million)
- Table 4 Europe Nk Cell Directed Antibodies In Natural Killer (Nk) Cell Therapeutics Market, By Region, 2018-2029 (Usd Million)
- Table 5 Europe Natural Killer (Nk) Cell Therapeutics Market, By Approaches, 2018-2029 (Usd Million)
- Table 6 Europe Antibody-dependent Cell-mediated Cytotoxicity (Adcc) In Natural Killer (Nk) Cell Therapeutics Market, By Region, 2018-2029 (Usd Million)
- Table 7 Europe Bi-specific Antibodies In Natural Killer (Nk) Cell Therapeutics Market, By Region, 2018-2029 (Usd Million)
- Table 8 Europe Natural Killer (Nk) Cell Therapeutics Market, By Application, 2019-2027 (Usd Million)
- Table 9 Europe Cancer In Natural Killer (Nk) Cell Therapeutics Market, By Region, 2018-2029 (Usd Million)
- Table 10 Europe Cancer In Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 11 Europe Hematologic Malignancies In Cancer Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 12 Europe Others In Natural Killer (Nk) Cell Therapeutics Market, By Region, 2018-2029 (Usd Million)
- Table 13 Europe Natural Killer (Nk) Cell Therapeutics Market, By End User, 2018-2029 (Usd Million)
- Table 14 Europe Hospitals In Natural Killer (Nk) Cell Therapeutics Market, By Region, 2018-2029 (Usd Million)
- Table 15 Europe Specialty Clinics In Natural Killer (Nk) Cell Therapeutics Market, By Region, 2018-2029 (Usd Million)
- Table 16 Europe Research And Academic Institutes In Natural Killer (Nk) Cell Therapeutics Market, By Region, 2018-2029 (Usd Million)
- Table 17 Europe Natural Killer (Nk) Cell Therapeutics Market, By Distribution Channel, 2018-2027 (Usd Million)
- Table 18 Europe Hospital Pharmacies In Natural Killer (Nk) Cell Therapeutics Market, By Region, 2018-2027 (Usd Million)
- Table 19 Europe Direct Tender In Natural Killer (Nk) Cell Therapeutics Market, By Region, 2018-2027 (Usd Million)
- Table 20 Europe Others In Natural Killer (Nk) Cell Therapeutics Market, By Region, 2018-2029 (Usd Million)
- Table 21 Europe Natural Killer (Nk) Cell Therapeutics Market, By Country, 2018-2029 (Usd Million)
- Table 22 Europe Natural Killer (Nk) Cell Therapeutics Market, By Therapeutics, 2018-2029 (Usd Million)
- Table 23 Europe Natural Killer (Nk) Cell Therapeutics Market, By Approaches, 2018-2029 (Usd Million)
- Table 24 Europe Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 25 Europe Cancer In Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 26 Europe Hematologic Malignancies In Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 27 Europe Natural Killer (Nk) Cell Therapeutics Market, By End User, 2018-2029 (Usd Million)
- Table 28 Europe Natural Killer (Nk) Cell Therapeutics Market, By Distribution Channel, 2018-2029 (Usd Million)
- Table 29 Germany Natural Killer (Nk) Cell Therapeutics Market, By Therapeutics, 2018-2029 (Usd Million)
- Table 30 Germany Natural Killer (Nk) Cell Therapeutics Market, By Approaches, 2018-2029 (Usd Million)
- Table 31 Germany Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 32 Germany Cancer In Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 33 Germany Hematologic Malignancies In Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 34 Germany Natural Killer (Nk) Cell Therapeutics Market, By End User, 2018-2029 (Usd Million)
- Table 35 Germany Natural Killer (Nk) Cell Therapeutics Market, By Distribution Channel, 2018-2029 (Usd Million)
- Table 36 France Natural Killer (Nk) Cell Therapeutics Market, By Therapeutics, 2018-2029 (Usd Million)
- Table 37 France Natural Killer (Nk) Cell Therapeutics Market, By Approaches, 2018-2029 (Usd Million)
- Table 38 France Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 39 France Cancer In Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 40 France Hematologic Malignancies In Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 41 France Natural Killer (Nk) Cell Therapeutics Market, By End User, 2018-2029 (Usd Million)
- Table 42 France Natural Killer (Nk) Cell Therapeutics Market, By Distribution Channel, 2018-2029 (Usd Million)
- Table 43 Italy Natural Killer (Nk) Cell Therapeutics Market, By Therapeutics, 2018-2029 (Usd Million)
- Table 44 Italy Natural Killer (Nk) Cell Therapeutics Market, By Approaches, 2018-2029 (Usd Million)
- Table 45 Italy Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 46 Italy Cancer In Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 47 Italy Hematologic Malignancies In Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 48 Italy Natural Killer (Nk) Cell Therapeutics Market, By End User, 2018-2029 (Usd Million)
- Table 49 Italy Natural Killer (Nk) Cell Therapeutics Market, By Distribution Channel, 2018-2029 (Usd Million)
- Table 50 U.K. Natural Killer (Nk) Cell Therapeutics Market, By Therapeutics, 2018-2029 (Usd Million)
- Table 51 U.K. Natural Killer (Nk) Cell Therapeutics Market, By Approaches, 2018-2029 (Usd Million)
- Table 52 U.K. Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 53 U.K. Cancer In Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 54 U.K. Hematologic Malignancies In Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 55 U.K. Natural Killer (Nk) Cell Therapeutics Market, By End User, 2018-2029 (Usd Million)
- Table 56 U.K. Natural Killer (Nk) Cell Therapeutics Market, By Distribution Channel, 2018-2029 (Usd Million)
- Table 57 Spain Natural Killer (Nk) Cell Therapeutics Market, By Therapeutics, 2018-2029 (Usd Million)
- Table 58 Spain Natural Killer (Nk) Cell Therapeutics Market, By Approaches, 2018-2029 (Usd Million)
- Table 59 Spain Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 60 Spain Cancer In Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 61 Spain Hematologic Malignancies In Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 62 Spain Natural Killer (Nk) Cell Therapeutics Market, By End User, 2018-2029 (Usd Million)
- Table 63 Spain Natural Killer (Nk) Cell Therapeutics Market, By Distribution Channel, 2018-2029 (Usd Million)
- Table 64 Netherlands Natural Killer (Nk) Cell Therapeutics Market, By Therapeutics, 2018-2029 (Usd Million)
- Table 65 Netherlands Natural Killer (Nk) Cell Therapeutics Market, By Approaches, 2018-2029 (Usd Million)
- Table 66 Netherlands Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 67 Netherlands Cancer In Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 68 Netherlands Hematologic Malignancies In Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 69 Netherlands Natural Killer (Nk) Cell Therapeutics Market, By End User, 2018-2029 (Usd Million)
- Table 70 Netherlands Natural Killer (Nk) Cell Therapeutics Market, By Distribution Channel, 2018-2029 (Usd Million)
- Table 71 Russia Natural Killer (Nk) Cell Therapeutics Market, By Therapeutics, 2018-2029 (Usd Million)
- Table 72 Russia Natural Killer (Nk) Cell Therapeutics Market, By Approaches, 2018-2029 (Usd Million)
- Table 73 Russia Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 74 Russia Cancer In Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 75 Russia Hematologic Malignancies In Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 76 Russia Natural Killer (Nk) Cell Therapeutics Market, By End User, 2018-2029 (Usd Million)
- Table 77 Russia Natural Killer (Nk) Cell Therapeutics Market, By Distribution Channel, 2018-2029 (Usd Million)
- Table 78 Switzerland Natural Killer (Nk) Cell Therapeutics Market, By Therapeutics, 2018-2029 (Usd Million)
- Table 79 Switzerland Natural Killer (Nk) Cell Therapeutics Market, By Approaches, 2018-2029 (Usd Million)
- Table 80 Switzerland Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 81 Switzerland Cancer In Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 82 Switzerland Hematologic Malignancies In Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 83 Switzerland Natural Killer (Nk) Cell Therapeutics Market, By End User, 2018-2029 (Usd Million)
- Table 84 Switzerland Natural Killer (Nk) Cell Therapeutics Market, By Distribution Channel, 2018-2029 (Usd Million)
- Table 85 Turkey Natural Killer (Nk) Cell Therapeutics Market, By Therapeutics, 2018-2029 (Usd Million)
- Table 86 Turkey Natural Killer (Nk) Cell Therapeutics Market, By Approaches, 2018-2029 (Usd Million)
- Table 87 Turkey Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 88 Turkey Cancer In Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 89 Turkey Hematologic Malignancies In Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 90 Turkey Natural Killer (Nk) Cell Therapeutics Market, By End User, 2018-2029 (Usd Million)
- Table 91 Turkey Natural Killer (Nk) Cell Therapeutics Market, By Distribution Channel, 2018-2029 (Usd Million)
- Table 92 Austria Natural Killer (Nk) Cell Therapeutics Market, By Therapeutics, 2018-2029 (Usd Million)
- Table 93 Austria Natural Killer (Nk) Cell Therapeutics Market, By Approaches, 2018-2029 (Usd Million)
- Table 94 Austria Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 95 Austria Cancer In Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 96 Austria Hematologic Malignancies In Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 97 Austria Natural Killer (Nk) Cell Therapeutics Market, By End User, 2018-2029 (Usd Million)
- Table 98 Austria Natural Killer (Nk) Cell Therapeutics Market, By Distribution Channel, 2018-2029 (Usd Million)
- Table 99 Norway Natural Killer (Nk) Cell Therapeutics Market, By Therapeutics, 2018-2029 (Usd Million)
- Table 100 Norway Natural Killer (Nk) Cell Therapeutics Market, By Approaches, 2018-2029 (Usd Million)
- Table 101 Norway Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 102 Norway Cancer In Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 103 Norway Hematologic Malignancies In Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 104 Norway Natural Killer (Nk) Cell Therapeutics Market, By End User, 2018-2029 (Usd Million)
- Table 105 Norway Natural Killer (Nk) Cell Therapeutics Market, By Distribution Channel, 2018-2029 (Usd Million)
- Table 106 Hungary Natural Killer (Nk) Cell Therapeutics Market, By Therapeutics, 2018-2029 (Usd Million)
- Table 107 Hungary Natural Killer (Nk) Cell Therapeutics Market, By Approaches, 2018-2029 (Usd Million)
- Table 108 Hungary Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 109 Hungary Cancer In Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 110 Hungary Hematologic Malignancies In Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 111 Hungary Natural Killer (Nk) Cell Therapeutics Market, By End User, 2018-2029 (Usd Million)
- Table 112 Hungary Natural Killer (Nk) Cell Therapeutics Market, By Distribution Channel, 2018-2029 (Usd Million)
- Table 113 Lithuania Natural Killer (Nk) Cell Therapeutics Market, By Therapeutics, 2018-2029 (Usd Million)
- Table 114 Lithuania Natural Killer (Nk) Cell Therapeutics Market, By Approaches, 2018-2029 (Usd Million)
- Table 115 Lithuania Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 116 Lithuania Cancer In Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 117 Lithuania Hematologic Malignancies In Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 118 Lithuania Natural Killer (Nk) Cell Therapeutics Market, By End User, 2018-2029 (Usd Million)
- Table 119 Lithuania Natural Killer (Nk) Cell Therapeutics Market, By Distribution Channel, 2018-2029 (Usd Million)
- Table 120 Ireland Natural Killer (Nk) Cell Therapeutics Market, By Therapeutics, 2018-2029 (Usd Million)
- Table 121 Ireland Natural Killer (Nk) Cell Therapeutics Market, By Approaches, 2018-2029 (Usd Million)
- Table 122 Ireland Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 123 Ireland Cancer In Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 124 Ireland Hematologic Malignancies In Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 125 Ireland Natural Killer (Nk) Cell Therapeutics Market, By End User, 2018-2029 (Usd Million)
- Table 126 Ireland Natural Killer (Nk) Cell Therapeutics Market, By Distribution Channel, 2018-2029 (Usd Million)
- Table 127 Poland Natural Killer (Nk) Cell Therapeutics Market, By Therapeutics, 2018-2029 (Usd Million)
- Table 128 Poland Natural Killer (Nk) Cell Therapeutics Market, By Approaches, 2018-2029 (Usd Million)
- Table 129 Poland Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 130 Poland Cancer In Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 131 Poland Hematologic Malignancies In Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 132 Poland Natural Killer (Nk) Cell Therapeutics Market, By End User, 2018-2029 (Usd Million)
- Table 133 Poland Natural Killer (Nk) Cell Therapeutics Market, By Distribution Channel, 2018-2029 (Usd Million)
- Table 134 Luxembourg Natural Killer (Nk) Cell Therapeutics Market, By Therapeutics, 2018-2029 (Usd Million)
- Table 135 Luxembourg Natural Killer (Nk) Cell Therapeutics Market, By Approaches, 2018-2029 (Usd Million)
- Table 136 Luxembourg Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 137 Luxembourg Cancer In Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 138 Luxembourg Hematologic Malignancies In Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 139 Luxembourg Natural Killer (Nk) Cell Therapeutics Market, By End User, 2018-2029 (Usd Million)
- Table 140 Luxembourg Natural Killer (Nk) Cell Therapeutics Market, By Distribution Channel, 2018-2029 (Usd Million)
- Table 141 Rest Of Europe Natural Killer (Nk) Cell Therapeutics Market, By Therapeutics, 2018-2029 (Usd Million)
- List Of Figures
- Figure 1 Europe Natural Killer (Nk) Cell Therapeutics Market: Segmentation
- Figure 2 Europe Natural Killer (Nk) Cell Therapeutics Market : Data Triangulation
- Figure 3 Europe Natural Killer (Nk) Cell Therapeutics Market: Droc Analysis
- Figure 4 Europe Natural Killer (Nk) Cell Therapeutics Market: Europe Vs Regional Market Analysis
- Figure 5 Europe Natural Killer (Nk) Cell Therapeutics Market: Company Research Analysis
- Figure 6 Europe Natural Killer (Nk) Cell Therapeutics Market: Multivariate Modelling
- Figure 7 Europe Natural Killer (Nk) Cell Therapeutics Market: Interview Demographics
- Figure 8 Europe Natural Killer (Nk) Cell Therapeutics Market: Dbmr Market Position Grid
- Figure 9 Europe Natural Killer (Nk) Cell Therapeutics Market: Vendor Share Analysis
- Figure 10 Europe Natural Killer (Nk) Cell Therapeutics Market: Segmentation
- Figure 11 North America Is Expected To Dominate And Asia-pacific Is Growing With The Fastest Pace In The Europe Natural Killer (Nk) Cell Therapeutics Market In The Forecast Period Of 2022 To 2029
- Figure 12 Increase In Usage Of Natural Killer Cells For The Treatment Of Cancer And Infectious Diseases And Rise In The Awareness About Immunotherapies Is Driving The Europe Natural Killer (Nk) Cell Therapeutics Market In The Forecast Period Of 2022 To 2029
- Figure 13 Nk Cell Therapies Segment Is Expected To Account For The Largest Share Of The Europe Natural Killer (Nk) Cell Therapeutics Market In 2022 & 2029
- Figure 14 Drivers, Restraints, Opportunities, And Challenges Of Europe Natural Killer (Nk) Cell Therapeutics Market
- Figure 15 Europe Natural Killer (Nk) Cell Therapeutics Market: By Therapeutics, 2021
- Figure 16 Europe Natural Killer (Nk) Cell Therapeutics Market: By Therapeutics, 2022-2029 (Usd Million)
- Figure 17 Europe Natural Killer (Nk) Cell Therapeutics Market: By Therapeutics, Cagr (2022-2029)
- Figure 18 Europe Natural Killer (Nk) Cell Therapeutics Market: By Therapeutics, Lifeline Curve
- Figure 19 Europe Natural Killer (Nk) Cell Therapeutics Market: By Approaches, 2021
- Figure 20 Europe Natural Killer (Nk) Cell Therapeutics Market: By Approaches, 2022-2029 (Usd Million)
- Figure 21 Europe Natural Killer (Nk) Cell Therapeutics Market: By Approaches, Cagr (2022-2029)
- Figure 22 Europe Natural Killer (Nk) Cell Therapeutics Market: By Approaches, Lifeline Curve
- Figure 23 Europe Natural Killer (Nk) Cell Therapeutics Market: By Application, 2020
- Figure 24 Europe Natural Killer (Nk) Cell Therapeutics Market: By Application, 2022-2029 (Usd Million)
- Figure 25 Europe Natural Killer (Nk) Cell Therapeutics Market: By Application, Cagr (2022-2029)
- Figure 26 Europe Natural Killer (Nk) Cell Therapeutics Market: By Application, Lifeline Curve
- Figure 27 Europe Natural Killer (Nk) Cell Therapeutics Market: By End User, 2021
- Figure 28 Europe Natural Killer (Nk) Cell Therapeutics Market: By End User, 2022-2029 (Usd Million)
- Figure 29 Europe Natural Killer (Nk) Cell Therapeutics Market: By End User, Cagr (2022-2029)
- Figure 30 Europe Natural Killer (Nk) Cell Therapeutics Market: By End User, Lifeline Curve
- Figure 31 Europe Natural Killer (Nk) Cell Therapeutics Market: By Distribution Channel, 2021
- Figure 32 Europe Natural Killer (Nk) Cell Therapeutics Market: By Distribution Channel, 2022-2029 (Usd Million)
- Figure 33 Europe Natural Killer (Nk) Cell Therapeutics Market: By Distribution Channel, Cagr (2022-2029)
- Figure 34 Europe Natural Killer (Nk) Cell Therapeutics Market: By Distribution Channel, Lifeline Curve
- Figure 35 Europe Natural Killer (Nk) Cell Therapeutics Market: Snapshot (2021)
- Figure 36 Europe Natural Killer (Nk) Cell Therapeutics Market: By Country (2021)
- Figure 37 Europe Natural Killer (Nk) Cell Therapeutics Market: By Country (2022 & 2029)
- Figure 38 Europe Natural Killer (Nk) Cell Therapeutics Market: By Country (2021 & 2029)
- Figure 39 Europe Natural Killer (Nk) Cell Therapeutics Market: By Therapeutics (2022-2029)
- Figure 40 Europe Natural Killer (Nk) Cell Therapeutics Market: Company Share 2021 (%)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
